Repeat of .23 cent run? The last run up to .23 cents

New Post Public Reply Private Reply Replies (1) Message Board
joey68
Repeat of .23 cent run?

The last run up to .23 cents was, in my opinion, due mostly to a constant stream of PRs. It died down, among other things, because distribution wasn't able to keep up with demand and investors became bored.

SCIE has an incredible amount of energy building right now. Check it out:

This year alone, we've had SEVEN PR's in 5 months. NONE contained fluff. I know of countless stocks that haven't had seven PR's in three years.

The 10Q should be coming out tomorrow.

The last company to have a licensing agreement with Duke sold to Toshiba for over $10 a share. SCIE now has a licensing agreement with Duke.

Oncoscope acquisition isn't a long forgotten memory. Something big is in the works.

SCIE is probably working on a second device as we speak for Barrett's esophagus which uses Duke/Oncoscope tech. When we get a PR for this, its going to get cray-cray in here.

Medtech2017 in January. SCIE is on the FRONT webpage under JOHNSON & JOHNSON. Free publicity doesn't get any better than that!

SCIE is building distribution in China as we speak.

Wavstat4 is in the middle east. Possible sales from Saudi Arabia this year.

Europe sales very possible this year.

England is slowly coming on board. Probably hear about them in 2017 (could be sooner).

Tons of free publicity. Twitter accounts are picking up Spectrascience's PRs.

Barrett's esophagus website for cancer treatment shows SCIE's PR for Duke's agreement with SCIE.

The 10K showed $6600 in sales. $825 per box of forceps x 8 boxes = $6600. Coincidence? I don't think so. Someone bought them.

Dr. Neumann, ridiculously well known in the endoscopy world, has mentioned the success of the WavSTAT numerous times. Among other things, he also wrote about PENTAX's iSCAN found on the same PETAX website where the Wavstat is displayed.

JagWorldwide showed a picture last Friday of the wavstat in SPAIN. Hospitals aren't going to waste time, money, and resources training doctors and nurses if they aren't planning on buying it!

Standard biopsies are archaic! We are an internet connected, technologically advanced society. Optical biopsies are not only the 'future' of biopsies, they are coming online right now.

SCIE is working with PENTAX! Owned by HOYA!

Wavstat is on the PENTAX website.

Wavstat works with bladder lesions.

SCIE is at the forefront in this field. They own many patents which wont expire until 2020+. CEO Oliver probably wants to sell SCIE well before 2020. He's a successful business man and probably wants to retire with a bang.

Wavstat showing up on UK's NHS website numerous times.

MORDIS trial in effect; recruiting live human beings.

SCIE is extremely transparent with investors.

Chart showing an obvious turn around in trend. Higher lows since November 2015.

The wavstat is a real product, used on real humans, showing real results. I don't know about anyone else, but this list shows me the risk/reward ratio is worth my investment.

Not investment advice.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Weight Loss Drugs Linked to Genetic Hair Loss in Men

Updated Category News Views 0

When weight loss turns hairy, it's not just an old wives' tale. We have some solid evidence from those eggheads at NYU Langone Health, who unearthed this hairy connection between popular weight loss drugs and the glinting domes of the genetically predisposed. Understanding the Hair-Drug Connection The name Ozempic might sound familiar, and not just because it's been...

Continue Reading
McLean Launches Program to Foster AI Capability

Updated Category News Views 2

Driving AI Adoption: A Shift Towards Human-Centric Learning McLean & Company has dropped an initiative that’s like laying fresh tracks for AI inclusion in businesses. Dubbed the Human-Centric AI Program, it’s a wake-up call to organizations struggling to shift AI from a novelty to a natural part of operations. This isn’t just about fiddling with AI tools; it’s...

Continue Reading
Ecobat's Strategic Shift: Exiting Lithium for Lead

Updated Category News Views 5

You ever get that sense of déjà vu when another company decides to jump ship from a supposedly hot market? Well, that's where Ecobat's at, folks. This global player in battery recycling just waved goodbye to its lithium recycling biz, closing the deal on its Arizona operations. Previously, they ditched similar holdings in the UK and Germany. Now, they're all-in on their...

Continue Reading
GoPro's $1.14 Buyout Scrutinized: Fair Value Debate

Updated Category News Views 2

Unpacking the GoPro Buyout Announcement There's some commotion brewing in the investor world, especially if you're clutching onto shares of GoPro (NASDAQ:GPRO). A $1.14 per share buyout has hit the spotlight, and folks are asking if this deal is kosher, particularly when there's $285 million on the line. Does the price truly reflect what GoPro's worth? Ademi LLP is...

Continue Reading
MD Integrations' Bold Cert Link: Telehealth's New Era

Updated Category News Views 2

MD Integrations Paves a New Path in Telehealth Well, folks, it seems someone’s finally listening. MD Integrations is taking a serious swing at solving one of telehealth's big hiccups – compliance delays. By roping in LegitScript directly, they’re all set to smooth the rocky road to launching virtual care brands. The Sticky Issue of Compliance Delays Anyone dabbling...

Continue Reading
Cango's EcoHash Marks AI Move with Key Milestones

Updated Category News Views 0

AI Expansion at EcoHash: A Strategic Stride Some days you wake up, read a company pushing its legacy into something new, and you just gotta wonder if they’ve hit paydirt or just blowing smoke. For Cango Inc. and its subsidiary EcoHash, this latest update is shaping up interesting. They're no small potatoes in mining Bitcoins, but they're now trying their hand at AI...

Continue Reading
Demand for Home Care Workers Soars: 850k by 2035

Updated Category News Views 5

A Looming Need for Home-based Care Take a long, deep breath and visualize this: by 2035, America's gonna need roughly 850,000 more home care workers. That's a head-spinning figure, and if you haven't been keeping up with the projections, let me fill you in on something the Bureau of Labor Statistics threw our way. They're saying home health and personal care aides will...

Continue Reading
TETRA Technologies to Engage at Key Investor Events

Updated Category News Views 3

Revving Up for Major Investor Conferences All eyes are on TETRA Technologies Inc. (NYSE:TTI) as they gear up to make splashy appearances at not one, but two high-profile investor conferences in New York. It's setting the stage for some potentially juicy conversations about where TTI, a player with deep roots in energy services, is heading in this whirlwind of an industry....

Continue Reading
Leopard Imaging's DragonFire Aims at Industrial Heat Tracking

Updated Category News Views 2

DragonFire: A New Player in Industrial Thermal Imaging Leopard Imaging is strutting onto the thermal imaging stage with a fresh piece of tech—DragonFire. Now, this ain't just another gadget in a long line of gizmos. Unlike your run-of-the-mill cameras, this one packs a punch with its high-resolution uncooled infrared capability. Imagine the kind of precision you can...

Continue Reading
Eluvio's Broadcast Revolution: Zero-Copy AI Streaming

Updated Category News Views 1

The Game-Changing Shift in Broadcast Tech Eluvio's latest reveal at IBC 2026 shows they've taken the gloves off in the broadcast arena. They're pitching an all-in-one Global Broadcast Fabric that's turning heads with its zero-copy distribution and inline AI capabilities. No more dilly-dallying with satellites or cumbersome cloud solutions. Instead, they've cut right to...

Continue Reading

Top 5 Most Recently Viewed Articles

Craneware Plc Disclosure: Insights into Ownership Positions

Updated Category News Views 202

Craneware Plc Disclosure Overview Craneware Plc has recently disclosed significant details regarding its share ownership and position disclosures, primarily emphasizing the stakes held by Rathbones Group Plc, which commands a notable presence in the market. Such disclosures are crucial within the context of the UK’s takeover regulations, particularly Rule 8 of the...

Continue Reading
60 Degrees Pharmaceuticals Public Offering: Key Details Explained

Updated Category News Views 130

60 Degrees Pharmaceuticals Announces Public Offering Details 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW), a dedicated pharmaceutical company, has made a significant announcement regarding its latest public offering aimed at funding its mission to develop innovative medicines for infectious diseases. This offering, which represents an important step in expanding...

Continue Reading
LifeMD Announces Exciting Quarterly Dividend for Stockholders

Updated Category News Views 128

LifeMD Unveils Quarterly Dividend for Preferred Stockholders LifeMD, Inc. (Nasdaq: LFMD), a top-tier provider in virtual primary care services, has officially proclaimed that its Board of Directors has approved a cash dividend for holders of the company’s Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP). This dividend is set at an attractive $0.5546875 per...

Continue Reading
A Comprehensive Look at Microsoft's Competitive Position in Software

Updated Category News Views 144

Understanding Microsoft's Market Performance In today's swiftly evolving business landscape, having a clear grasp of a company's standing can significantly benefit investors and enthusiasts alike. This analysis focuses on Microsoft (NASDAQ: MSFT) and its positioning within the competitive software industry. By examining various financial metrics and growth potentials, we...

Continue Reading
Understanding FuboTV's Short Interest and Market Dynamics

Updated Category News Views 325

Understanding FuboTV's Short Interest FuboTV's short percent of float has recently seen an increase of 3.67%. This statistic indicates that the company has a substantial 43.41 million shares sold short, which accounts for approximately 12.99% of all shares that are publicly available for trading. Notably, the current trading environment suggests it would take around 4.19...

Continue Reading